PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis

30Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 31-year-old man previously treated with chemotherapy for metastatic testicular cancer presented with new mediastinal lymphadenopathy and peripheral lung opacities. Serum tumour markers were not elevated and a PET (positron emission tomography) scan revealed increased FDG (fluoro-deoxyglucose) uptake in the lungs and mediastinum consistent with testis cancer relapse. A biopsy of a mediastinal lymph node was performed and the pathology was that of sarcoidosis. Immunohistochemistry however was positive for PLAP (placental alkaline phosphatase) and negative for EMA (epithelial membrane antigen). This immunohistochemical profile raised concerns that the observed pathology represented a sarcoid reaction to micro-metastatic testicular cancer relapse. We performed immunohistochemical pathology analysis on four known cases of sarcoidosis and found the same immunohistochemical-staining pattern. This case highlights the problem of specificity when interpreting the significance of PET scans and immunohistochemical analysis in this situation. Sarcoidosis, a condition that has been associated with testicular cancer, should always be considered in the differential diagnosis.

Cite

CITATION STYLE

APA

Karapetis, C. S., Strickland, A. H., Yip, D., Walt, J. D. V. D., & Harper, P. G. (2001). PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis. Annals of Oncology, 12(10), 1485–1488. https://doi.org/10.1023/A:1012548312538

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free